Skip to main content
. 2018 Nov;10(11):5991–6001. doi: 10.21037/jtd.2018.10.50

Table S2. Number (percentage) of patients with a positive result by illness severity and age group.

Illness severity Age group (years) Cases Patients with a positive result (%)
PIV HBoV HRV CoV Flu HMPV AdV RSV EV MP CP Over
CAP (n=6,008) 0–1 449 41 (9.1) 17 (3.8) 35 (7.8) 6 (1.3) 20 (4.5) 18 (4.0) 14 (3.1) 51 (11.4) 12 (2.7) 11 (2.4) 0 (0) 191 (42.5)
2–4 748 72 (9.6) 10 (1.3) 42 (5.6) 20 (2.7) 62 (8.3) 34 (4.5) 22 (2.9) 69 (9.2) 25 (3.3) 27 (3.6) 0 (0) 328 (43.9)
5–9 510 37 (7.3) 4 (0.8) 30 (5.9) 4 (0.8) 32 (6.3) 14 (2.7) 14 (2.7) 21 (4.1) 17 (3.3) 91 (17.8) 1 (0.2) 222 (43.5)
10–17 218 12 (5.5) 2 (0.9) 11 (5.0) 2 (0.9) 13 (6.0) 3 (1.4) 5 (2.3) 4 (1.8) 4 (1.8) 37 (17) 4 (1.8) 78 (35.8)
18–44 805 21 (2.6) 4 (0.5) 32 (4.0) 10 (1.2) 63 (7.8) 5 (0.6) 13 (1.6) 8 (1.0) 8 (1.0) 136 (16.9) 10 (1.2) 283 (35.2)
45–64 1,085 32 (2.9) 1 (0.1) 23 (2.1) 24 (2.2) 100 (9.2) 20 (1.8) 12 (1.1) 16 (1.5) 8 (0.7) 51 (4.7) 0 (0) 256 (23.6)
65–79 1,190 37 (3.1) 9 (0.8) 45 (3.8) 33 (2.8) 110 (9.2) 19 (1.6) 7 (0.6) 23 (1.9) 19 (1.6) 10 (0.8) 1 (0.1) 287 (24.1)
≥8yr 1,003 26 (2.6) 3 (0.3) 28 (2.8) 22 (2.2) 96 (9.6) 16 (1.6) 7 (0.7) 23 (2.3) 15 (1.5) 9 (0.9) 1 (0.1) 227 (22.6)
Total 6,008 278 (4.6) 50 (0.8) 246 (4.1) 121 (2.0) 496 (8.3) 129 (2.1) 94 (1.6) 215 (3.6) 108 (1.8) 372 (6.2) 17 (0.3) 1,872 (31.2)
NSCAP (n=4,937) 0–1 307 23 (7.5) 13 (4.2) 22 (7.2) 4 (1.3) 17 (5.5) 14 (4.6) 9 (2.9) 37 (12.1) 10 (3.3) 8 (2.6) 0 (0) 132 (43)
2–4 691 70 (10.1) 10 (1.4) 37 (5.4) 19 (2.7) 59 (8.5) 34 (4.9) 22 (3.2) 63 (9.1) 24 (3.5) 25 (3.6) 0 (0) 310 (44.9)
5–9 455 30 (6.6) 4 (0.9) 28 (6.2) 4 (0.9) 30 (6.6) 14 (3.1) 14 (3.1) 19 (4.2) 14 (3.1) 81 (17.8) 1 (0.2) 199 (43.7)
10–17 198 11 (5.6) 2 (1.0) 9 (4.5) 2 (1.0) 10 (5.1) 3 (1.5) 5 (2.5) 3 (1.5) 4 (2.0) 34 (17.2) 3 (1.5) 69 (34.8)
18–44 774 20 (2.6) 4 (0.5) 32 (4.1) 9 (1.2) 60 (7.8) 5 (0.6) 12 (1.6) 6 (0.8) 7 (0.9) 135 (17.4) 10 (1.3) 274 (35.4)
45–64 952 27 (2.8) 1 (0.1) 20 (2.1) 21 (2.2) 89 (9.3) 15 (1.6) 10 (1.1) 13 (1.4) 8 (0.8) 50 (5.3) 0 (0) 227 (23.8)
65–79 887 27 (3.0) 7 (0.8) 34 (3.8) 24 (2.7) 81 (9.1) 17 (1.9) 5 (0.6) 16 (1.8) 16 (1.8) 7 (0.8) 1 (0.1) 217 (24.5)
≥80 673 12 (1.8) 2 (0.3) 17 (2.5) 17 (2.5) 68 (10.1) 11 (1.6) 3 (0.4) 16 (2.4) 11 (1.6) 8 (1.2) 0 (0) 153 (22.7)
Total 4,937 220 (4.5) 43 (0.9) 199 (4.0) 100 (2.0) 414 (8.4) 113 (2.3) 80 (1.6) 173 (3.5) 94 (1.9) 348 (7.0) 15 (0.3) 1,581 (32)
SCAP (n=1,071) 0–1 142 18 (12.7) 4 (2.8) 13 (9.2) 2 (1.4) 3 (2.1) 4 (2.8) 5 (3.5) 14 (9.9) 2 (1.4) 3 (2.1) 0 (0) 59 (41.5)
2–4 57 2 (3.5) 0 (0) 5 (8.8) 1 (1.8) 3 (5.3) 0 (0) 0 (0) 6 (10.5) 1 (1.8) 2 (3.5) 0 (0) 18 (31.6)
5–9 55 7 (12.7) 0 (0) 2 (3.6) 0 (0) 2 (3.6) 0 (0) 0 (0) 2 (3.6) 3 (5.5) 10 (18.2) 0 (0) 23 (41.8)
10–17 20 1 (5.0) 0 (0) 2 (10.0) 0 (0) 3 (15.0) 0 (0) 0 (0) 1 (5.0) 0 (0) 3 (15.0) 1 (5.0) 9 (45.0)
18–44 31 1 (3.2) 0 (0) 0 (0) 1 (3.2) 3 (9.7) 0 (0) 1 (3.2) 2 (6.5) 1 (3.2) 1 (3.2) 0 (0) 9 (29.0)
45–64 133 5 (3.8) 0 (0) 3 (2.3) 3 (2.3) 11 (8.3) 5 (3.8) 2 (1.5) 3 (2.3) 0 (0) 1 (0.8) 0 (0) 29 (21.8)
65–79 303 10 (3.3) 2 (0.7) 11 (3.6) 9 (3.0) 29 (9.6) 2 (0.7) 2 (0.7) 7 (2.3) 3 (1.0) 3 (1.0) 0 (0) 70 (23.1)
≥80 330 14 (4.2) 1 (0.3) 11 (3.3) 5 (1.5) 28 (8.5) 5 (1.5) 4 (1.2) 7 (2.1) 4 (1.2) 1 (0.3) 1 (0.3) 74 (22.4)
Total 1,071 58 (5.4) 7 (0.7) 47 (4.4) 21 (2.0) 82 (7.7) 16 (1.5) 14 (1.3) 42 (3.9) 14 (1.3) 24 (2.2) 2 (0.2) 291 (27.2)

CAP, community-acquired pneumonia; NSCAP, non-severe CAP; SCAP, severe CAP; HBoV, human bocavirus; HRV, human rhinovirus; CoV, coronavirus; Flu, influenza A or B virus; HMPV, human metapneumovirus; AdV, adenovirus; RSV, respiratory syncytial virus; PIV, parainfluenza virus; EV, enterovirus; MP, Mycoplasma pneumoniae; CP, Chlamydophila pneumoniae.